Literature DB >> 13104417

On the relationship of urinary copper excretion to the aminoaciduria in Wilson's disease (hepatolenticular degeneration).

L L UZMAN.   

Abstract

Entities:  

Keywords:  AMINO ACIDS/in urine; COPPER/in urine; HEPATOLENTICULAR DEGENERATION/urine in; URINE

Mesh:

Substances:

Year:  1953        PMID: 13104417     DOI: 10.1097/00000441-195312000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  8 in total

1.  Blood copper and its relationship to the globulins.

Authors:  J N CUMINGS; H J GOODWIN; C J EARL
Journal:  J Clin Pathol       Date:  1955-02       Impact factor: 3.411

2.  HEPATO-LENTICULAR degeneration.

Authors: 
Journal:  Br Med J       Date:  1956-01-28

3.  The dietary availability of copper in the form of naturally occurring organic complexes.

Authors:  C F MILLS
Journal:  Biochem J       Date:  1956-06       Impact factor: 3.857

4.  Studies on copper metabolism. XIII. Hepatolenticular degeneration.

Authors:  G E CARTWRIGHT; R E HODGES; C J GUBLER; J P MAHONEY; K DAUM; M M WINTROBE; W B BEAN
Journal:  J Clin Invest       Date:  1954-11       Impact factor: 14.808

5.  Nephrotoxic Properties of Copper under Experimental Conditions in Mice: With Special Reference to the Pathogenesis of the Renal Alterations in Wilson's Disease.

Authors:  F S Vogel
Journal:  Am J Pathol       Date:  1960-06       Impact factor: 4.307

6.  The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson's disease).

Authors:  W B MATTHEWS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-11       Impact factor: 10.154

7.  Penicillamine neurotoxicity: an hypothesis.

Authors:  J M Walshe
Journal:  ISRN Neurol       Date:  2011-07-21

8.  THE DEPOSITION OF EXOGENOUS COPPER UNDER EXPERIMENTAL CONDITIONS WITH OBSERVATIONS ON ITS NEUROTOXIC AND NEPHROTOXIC PROPERTIES IN RELATION TO WILSON'S DISEASE.

Authors:  F S Vogel
Journal:  J Exp Med       Date:  1959-10-31       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.